Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer

Affiliations

¹ Department of Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
² Nantong Tumor Hospital, Nantong, China.
³ State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing, China.
⁴ Department of Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. lujw@medmail.com.cn.
⁵ Keaise Center for Clinical Laboratory, Wuhan, China. 18911420767@163.com.

Published Erratum

Wei Peng et al. Sci Rep. 2020.

. 2020 Oct 14;10(1):17254.

doi: 10.1038/s41598-020-70071-5.

¹ Department of Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
² Nantong Tumor Hospital, Nantong, China.
³ State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing, China.
⁴ Department of Medicine, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. lujw@medmail.com.cn.
⁵ Keaise Center for Clinical Laboratory, Wuhan, China. 18911420767@163.com.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.
Peng W, Zhou Z, Zhong Y, Sun Y, Wang Y, Zhu Z, Jiao W, Bai M, Sun J, Lu J, Yin H. Peng W, et al. Sci Rep. 2019 Dec 13;9(1):19084. doi: 10.1038/s41598-019-55641-6. Sci Rep. 2019. PMID: 31836775 Free PMC article.